0000874015-17-000063.txt : 20171020 0000874015-17-000063.hdr.sgml : 20171020 20171020173425 ACCESSION NUMBER: 0000874015-17-000063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171018 FILED AS OF DATE: 20171020 DATE AS OF CHANGE: 20171020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARSHALL B LYNNE CENTRAL INDEX KEY: 0001073385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 171147760 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-10-18 0000874015 IONIS PHARMACEUTICALS INC IONS 0001073385 PARSHALL B LYNNE C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 1 0 0 COO Common Stock 2017-10-18 2017-10-18 4 M 0 7785 14.69 A 33526 D Common Stock 2017-10-18 2017-10-18 4 S 0 7785 65.00 D 25741 D Common Stock 2017-10-18 2017-10-18 4 M 0 8333 39.87 A 34074 D Common Stock 2017-10-18 2017-10-18 4 S 0 8333 65.00 D 25741 D Employee Stock Option (right to buy) 14.69 2017-10-18 2017-10-18 4 M 0 7785 0 D 2017-01-02 2020-01-29 Common Stock 7785 0 D Employee Stock Option (right to buy) 39.87 2017-10-18 2017-10-18 4 M 0 8333 0 D 2015-01-02 2021-01-01 Common Stock 8333 74167 D Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 8/8/2017. Grant of 1/2/2014 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 1/2/2015. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 20,625 shares per year. Following this transaction, the option was exercisable as to 69,010 on 10/18/2017. /s/B. Lynne Parshall 2017-10-20